SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 156 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 5.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $39,000 | +56.0% | 2,186 | +2.4% | 0.00% | – |
Q3 2017 | $25,000 | +4.2% | 2,134 | -7.8% | 0.00% | – |
Q2 2017 | $24,000 | 0.0% | 2,315 | +4.0% | 0.00% | – |
Q1 2017 | $24,000 | +14.3% | 2,226 | +38.3% | 0.00% | – |
Q4 2016 | $21,000 | +2000.0% | 1,610 | +1510.0% | 0.00% | – |
Q2 2016 | $1,000 | – | 100 | +4900.0% | 0.00% | – |
Q1 2016 | $0 | – | 2 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 2 | 0.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 2 | -99.7% | 0.00% | – |
Q2 2015 | $12,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |